|
Volumn 21, Issue 1, 2002, Pages 119-127
|
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family
a,b a a c d a,e a |
Author keywords
EGf; Her1 her2 inhibitors; Nci drug screen; Oncogenes; Signal transduction
|
Indexed keywords
4 (3 BROMOANILINO) 6 (METHYLAMINO)PYRIDO[3,4 D]PYRIMIDINE;
4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE;
4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE;
ANTINEOPLASTIC AGENT;
CANERTINIB;
CYCLIN D1;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MITOGEN ACTIVATED PROTEIN KINASE;
N [4 (3 BROMOANILINO) 6 QUINAZOLINYL]ACRYLAMIDE;
PD 153717;
PD 158735;
PD 165557;
PD 166075;
PD 166285;
PD 167978;
PD 168735;
PD 168780;
PD 168833;
PD 169404;
PD 169540;
PD 169541;
PD 170058;
PD 170062;
PD 170257;
PD 170459;
PROTEIN INHIBITOR;
PROTEIN P21;
PROTEIN P53;
QUINAZOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ARTICLE;
BREAST CANCER;
CANCER CELL;
CELL CYCLE G1 PHASE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DRUG SCREENING;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
CELL CYCLE;
CELL LINE, TRANSFORMED;
CYCLIN D1;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DRUG RESISTANCE, NEOPLASM;
ENZYME INDUCTION;
ENZYME INHIBITORS;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MALE;
MAP KINASE SIGNALING SYSTEM;
NEOPLASM PROTEINS;
NEOPLASMS;
PYRIMIDINES;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
TRANSFORMING GROWTH FACTOR ALPHA;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
TYRPHOSTINS;
|
EID: 0037012036
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1205028 Document Type: Article |
Times cited : (92)
|
References (33)
|